Browsing Over 414 Presentations

Sort By
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31) Industry Satellite Symposium

Debate with the delegates led by: (ID 820)

Lecture Time
12:40 - 13:00
Speakers
  • Pier Franco Conte (Padova, Italy)
Session Name
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Expanding the evidence base for CDK4/6 inhibitors (ID 737)

Lecture Time
12:05 - 12:25
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31) Industry Satellite Symposium

What is the basis of resistance to current ER+ therapies and what is the magnitude of the clinical problem? (ID 818)

Lecture Time
12:00 - 12:10
Speakers
  • Pier Franco Conte (Padova, Italy)
Session Name
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Audience question & answer (ID 740)

Lecture Time
12:50 - 13:00
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Considerations for PIK3CA mutations: An interactive discussion (ID 738)

Lecture Time
12:35 - 12:50
Speakers
  • Nicholas C. Turner (London, United Kingdom)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31) Industry Satellite Symposium

What are the broad strategies for mutation directed therapy? Is there a role for an orally-available Selective ER alpha Covalent Antagonist (SERCA)? (ID 819)

Lecture Time
12:10 - 12:40
Speakers
  • Dejan Juric (Boston, MA, United States of America)
Session Name
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Welcome and introduction (ID 736)

Lecture Time
12:00 - 12:05
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

Closing remarks (ID 817)

Lecture Time
13:00 - 13:00
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

The advancing role of PI3K inhibitors (ID 739)

Lecture Time
12:25 - 12:35
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Opening and welcome (ID 2) Opening session

Opening and welcome (ID 867)

Lecture Time
13:30 - 13:45
Speakers
  • Giuseppe Curigliano (Milan, Italy)
  • Sibylle Loibl (Neu-Isenburg, Germany)
Session Name
Opening and welcome (ID 2)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
13:30 - 13:45
The ESMO Breast Cancer Award (ID 3) Keynote lecture

Award Lecture (ID 1)

Lecture Time
13:45 - 14:15
Speakers
  • Jonas Bergh (Solna, Solna, Sweden)
Session Name
The ESMO Breast Cancer Award (ID 3)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
13:45 - 14:15
Early breast cancer: HER2 positive (ID 4) Educational session

Extended adjuvant therapy (ID 5)

Lecture Time
15:30 - 15:50
Speakers
  • Miguel Martín (Madrid, Spain)
Session Name
Early breast cancer: HER2 positive (ID 4)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00